OpenLegislation

Part 3 Monitoring for indicative dose and analytical performance characteristicsF1

Repealed

  1. 5Monitoring for compliance with the indicative dose
  2. 6Monitoring for compliance with the indicative dose
  3. 7Screening for certain radionuclides, or screening for an individual radionuclide
  4. 8Screening for certain radionuclides, or screening for an individual radionuclide
  5. 9Screening strategies for gross alpha activity and gross beta activity
  6. 10Screening strategies for gross alpha activity and gross beta activity
  7. 11Screening strategies for gross alpha activity and gross beta activity
  8. 12Screening strategies for gross alpha activity and gross beta activity
  9. 12Calculation of the indicative dose
  10. 13Calculation of the indicative dose
  11. 14Performance characteristics and methods of analysis

Annotations

Textual amendments

F1

Regulations revoked (20.11.2017) by The Private Water Supplies (Wales) Regulations 2017 (S.I. 2017/1041), regs. 1, 24(1)(a) (with regs. 3, 26(1)-(3))

[Editorial note: No historical revised versions have been created for amendments to this S.I. made prior to its final revocation. A revised version of how the S.I. stood at its first commencement is available and, to see the document content as it originally stood when it was made, select the 'Original (As Made)' version. For further details of the amendments see the List of All Changes available in 'More Resources']